You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Phase I Clinical Trial Candidates

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Monkeypox Trial (BNT166a, BNT166c)

Not yet recruiting
  • Monkeypox
  • BNT166a
  • BNT166c
  • (no location specified)
Aug 4, 2023

Malaria, Malaria,Falciparum, Parasitic Disease Trial in Oxford (RH5.1 and/or RH5.2-VLP with Matrix-M)

Not yet recruiting
  • Malaria
  • +4 more
  • RH5.1 and/or RH5.2-VLP with Matrix-M
  • Oxford, Oxfordshire, United Kingdom
    Centre for Clinical Vaccinology & Tropical Medicine (CCVTM)
Jul 27, 2023

Leukemia, Myeloid, Acute Trial in Worldwide (Azacitidine, Cusatuzumab)

Active, not recruiting
  • Leukemia, Myeloid, Acute
  • Darlinghurst, Australia
  • +55 more
Dec 28, 2022

Covid19 Trial in South Africa, United Kingdom (CST-2: EIDD-2801, CST-2: Placebo, Nitazoxanide)

Recruiting
  • Covid19
  • CST-2: EIDD-2801
  • +6 more
  • Cape Town, South Africa
  • +5 more
Aug 9, 2022

Atopic Dermatitis, Atopic Hand Eczema Trial (Tralokinumab, Placebo)

Not yet recruiting
  • Atopic Dermatitis
  • Atopic Hand Eczema
  • (no location specified)
Jul 13, 2023

Advanced Solid Tumors Trial (SHR-1826)

Not yet recruiting
  • Advanced Solid Tumors
  • (no location specified)
Oct 16, 2023

High-risk Non-muscle Invasive Bladder Cancer Trial (SHR-2005)

Not yet recruiting
  • High-risk Non-muscle Invasive Bladder Cancer
  • (no location specified)
Oct 25, 2023

SARS-CoV-2 Infection, COVID-19 Trial in United States (BNT162b2 (Omi XBB.1.5))

Not yet recruiting
  • SARS-CoV-2 Infection
  • COVID-19
  • BNT162b2 (Omi XBB.1.5)
  • Dublin, California
  • +14 more
Aug 10, 2023

Advanced Malignant Tumor Trial (SHR-5495 for injection)

Not yet recruiting
  • Advanced Malignant Tumor
  • SHR-5495 for injection
  • (no location specified)
Sep 26, 2023

Advanced Solid Tumor Trial (HLX43)

Not yet recruiting
  • Advanced Solid Tumor
  • (no location specified)
Oct 30, 2023

Influenza, Human, COVID-19 Trial in United States (bivalent BNT162b2 (original/Omi BA.4/BA.5), qIRV (22/23), QIV)

Recruiting
  • Influenza, Human
  • COVID-19
  • bivalent BNT162b2 (original/Omi BA.4/BA.5)
  • +2 more
  • Athens, Alabama
  • +18 more
Dec 22, 2022

Solid Tumor, Positron-Emission Tomography(PET) Trial in Shanghai (68Ga-NOTA-SNA002)

Not yet recruiting
  • Solid Tumor
  • Positron-Emission Tomography(PET)
  • Shanghai, China
    Zhongshan Hospital Affiliated to Fudan University
Aug 4, 2023

Multiple Myeloma Trial (AZD0305)

Not yet recruiting
  • Multiple Myeloma
  • (no location specified)
Oct 24, 2023

Non-muscular Invasive Bladder Cancer Trial in Changsha (BCG for therapeutic use)

Not yet recruiting
  • Non-muscular Invasive Bladder Cancer
  • BCG for therapeutic use
  • Changsha, China
    Hunan Cancer Hospital
Oct 20, 2023

Patients With Advanced Solid Tumors Trial in Beijing (TCC1727 tablet)

Not yet recruiting
  • Patients With Advanced Solid Tumors
  • TCC1727 tablet
  • Beijing, No.17, Panjiayuan Nanli, Chaoyang District, Beijing, China
    Cancer Hospital Chinese Academy of Medical Sciences
Jul 23, 2023

NSCLC Trial (Phase I - Mirdametinib - Level 1, Phase II - Mirdametinib, Phase I - Mirdametinib - Level 2)

Not yet recruiting
  • Non-Small Cell Lung Cancer
  • Phase I - Mirdametinib - Level 1
  • +4 more
  • (no location specified)
Jul 7, 2023

Advanced Malignant Tumor Trial (HRS-2189 Tablets)

Not yet recruiting
  • Advanced Malignant Tumor
  • HRS-2189 Tablets
  • (no location specified)
May 6, 2023

CAR-T Trial in Hangzhou (GC012F injection)

Recruiting
  • CAR-T
  • GC012F injection
  • Hangzhou, Zhejiang, China
    The First Affiliated Hospital,College of Medicine, Zhejiang Univ
May 10, 2023

Recurrent DLBCL, Refractory Diffuse Large B-cell Lymphoma Trial in Tianjin (RC19D2 cell injection)

Recruiting
  • Recurrent Diffuse Large B-Cell Lymphoma
  • Refractory Diffuse Large B-cell Lymphoma
  • RC19D2 cell injection
  • Tianjin, Tianjin, China
    Hematology Hospital of the Chinese Academy of Medical Sciences
Sep 14, 2023

Prostate Cancer Trial (HRS-9815 injection)

Not yet recruiting
  • Prostate Cancer
  • HRS-9815 injection
  • (no location specified)
Sep 25, 2023

Hypertension, Dyslipidemias Trial (CKD-348(6), CKD-828, D097, D337)

Not yet recruiting
  • Hypertension
  • Dyslipidemias
  • (no location specified)
Oct 29, 2023

Hematologic Malignancy Trial in Tianjin (BR108 injection)

Recruiting
  • Hematologic Malignancy
  • BR108 injection
  • Tianjin, Tianjin, China
    Tianjin Medical University Cancer Institute and Hospital
Aug 25, 2023

Malignant Pleural Effusion Trial in Wuhan (JMKX000197)

Recruiting
  • Malignant Pleural Effusion
  • Wuhan, Hubei, China
    Zhongnan Hospital of Wuhan University
Jun 25, 2023

Hand, Foot and Mouth Disease, Herpangina Trial in Chuxiong (low dose Bivalent Enterovirus Vaccine (Vero Cell), Inactivated,

Recruiting
  • Hand, Foot and Mouth Disease
  • Herpangina
  • low dose Bivalent Enterovirus Vaccine (Vero Cell), Inactivated
  • +3 more
  • Chuxiong, Yunnan, China
    Dayao County Center for Disease Control and Prevention
Sep 25, 2023

Overweight or Obesity Trial in Uppsala (Xenical® vs EMP 22, EMP 22 vs Xenical®, EMP 16 vs Xenical®)

Not yet recruiting
  • Overweight or Obesity
  • Xenical® vs EMP 22
  • +2 more
  • Uppsala, Sweden
    CTC Clinical Trial Consultanta AB
Aug 25, 2023